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Abstract
Background: Constitutional delay of growth and puberty (CDGP) is a variation of the onset and timing of pubertal
development without a defined endocrine abnormality. Recently published studies indicate that leptin and ghrelin
play a role in puberty initiation and progress. They have been implicated in regulation of GnRH secretion, with
ghrelin having inhibitory and leptin, facilitatory effects. We hypothesized that elevated ghrelin and reduced leptin
concentrations could be implicated in altering the tempo of puberty in adolescents with CDGP. So in the current
study we evaluate variations in leptin and ghrelin levels in adolescent boys with CDGP, the relationships between
both hormones and reproductive hormones including LH, FSH and testosterone were also evaluated.
Methods: The study enrolled 23 adolescent boys with CDGP and 20 healthy controls matched for age and sex.
Weight, height, BMI, testicular volume, bone age, bone age delay, serum FSH, LH, testosterone, leptin and ghrelin
were assessed.
Results: Adolescent boys with CDGP had significantly lower leptin and higher ghrelin than normal controls. Leptin
was positively correlated with BMI, bone age, testicular volume, FSH, LH and testosterone and negatively correlated
with delayed bone age and ghrelin. Ghrelin was negatively correlated with BMI, bone age, testicular volume, FSH,
LH and testosterone. With multiple regression analysis BMI, FSH, LH, testosterone and ghrelin remained
independently correlated with leptin while BMI, LH and testosterone remained independently correlated with
ghrelin.
Conclusion: Elevated serum ghrelin and decreased leptin concentrations and their associations with reproductive
hormones may explain the sexual immaturity in adolescent boys with CDGP.
Background
Constitutional delay of growth and puberty (CDGP) is a
disorder occurring in healthy adolescents who have
short stature compared with their peers, delay in bone
maturation and delayed puberty [1]. Most children with
CDGP begin to deviate from the normal growth curve
before age 2 yr, subsequently grow at a relatively normal
velocity, and then have a delayed pubertal growth spurt
[2]. In boys with CDGP, a testicular volume of 3-4 ml is
first reached when they are more than 13.7 years old.
The sleep related Luteinizing hormone (LH) increase
that characterizes the onset of puberty, is normally
present in CDGP. The LH response to Luteinizing hor-
mone releasing hormone (LHRH) analogues is inter-
mediate between that of hypogonadal patients and
normal pubertal children [3]. CDGP represents the
extreme tail of the normal distribution, aggregates in
families [4] and is much more common in boys [5]. A
suspected diagnosis of CDGP can be definitely con-
firmed only when puberty and the pubertal growth
spurt finally do occur spontaneously, more than two
standard deviations later than the normal mean age.
Pubertal development and fertility are determined by a
multi-hormonal effect. Puberty is characterized by
increasing concentrations of gonadal estradiol in girls
and testosterone in boys, driven by increasing concen-
trations of pituitary gonadotrophins which are, in turn,
regulated by gonadotrophin-releasing hormone (GnRH)
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defect in any of the components of this hormonal com-
plex directly affects puberty and reproduction in either
gender. Recent research added two new members to this
hormonal complex, namely leptin and ghrelin [8,9],
which are secreted by adipose tissue and gastrointestinal
tract, respectively. Besides their effect on carbohydrate
and fat metabolism and appetite, these hormones acting
on the hypothalamic-pituitary-gonadal axis, exert var-
ious effects on reproductive function [7].
Leptin, an adipocyte-derived hormone, is a key regula-
tor of energy homeostasis and adiposity. It acts directly
on hypothalamic nuclei to suppress food intake and
increase energy expenditure [10]. In addition, leptin has
been proposed to contribute to hypothalamic-pituitary-
gonadal function [11]. Indeed, leptin is clearly significant
in pubertal development and progression in humans
[12]; congenital leptin deficiency due to mutations in
either the leptin gene or the leptin receptor gene, is
associated with early-onset obesity and no pubertal
development [12,13].
Ghrelin is a 28-amino acid peptide produced in a vari-
ety of human tissues; however the major source of cir-
culating ghrelin is the stomach [14]. It regulates a large
array of endocrine and non endocrine functions, includ-
ing the control of growth hormone (GH) secretion, food
intake, energy balance and control of adiposity [15].
Ghrelin is the endogenous ligand for the GH secretago-
gue receptor (GHS-R) [14]. Together, ghrelin and
growth hormone releasing hormone (GHRH) synergisti-
cally increase GH levels [16]. Ghrelin stimulates appetite
and induces a positive energy balance that can lead to
w e i g h tg a i n[ 1 7 ] .I na d d i t i o n ,g h r e l i nr e d u c e sG n R H
secretion in the pre-pubertal period [18].
The aim of the present study was to investigate the
variations in leptin and ghrelin levels in adolescent boys
with CDGP, the relationships between both hormones
and reproductive hormones including LH, Follicle
stimulating hormone (FSH) and testosterone were also
evaluated.
Methods
The study comprised twenty three adolescent boys aged
14-16 years with CDGP (Table 1).
The diagnosis of CDGP was based on the following
criteria:
1) Short stature (height less than 2SD below the
mean)
2) Delayed puberty (onset delayed by more than 2SD-
that is, has not achieved 4 ml testes until aged 14 years).
3) Bone age below the 10
th centile for chronological
age (delayed by more than 1.5 years).
3) Absence of other causes of delayed puberty on his-
tory, examination and investigations. None of the parti-
cipants was taking any medication.
Height and weight were measured using standard pro-
cedures. Body mass index (BMI) was calculated from
the weight in kilograms divided by the square of the
height in meters. Pubertal stage was assessed according
to the method of Tanner and Whitehouse [19]. Skeletal
age was determined on left wrist radiographs using
Greulich and Pyle method. Bone age delay was noted as
the difference between skeletal and chronological age.
Twenty healthy adolescent boys matched for age in the
mid and late pubertal stage (3-5 Tanner stage) were
evaluated as controls.
All adolescents with CDGP subsequently attain pub-
erty either spontaneously (15 boys) or after induction of
puberty (8 boys). They progress through puberty with
increasing testicular volumes and pubertal staging.
Hormone assays
To assess episodic hormone secretion, 3 ml fasting
blood samples were collected at 20 minutes intervals for
3 hours and the separated sera were mixed for the
quantitative determination of ghrelin, leptin, FSH, LH
and testosterone. Seum leptin levels were estimated by
an enzyme immunoassay test that follows a typical two-
Step capture (sandwitch) assay. (Diagnostic Biochem
Canada Inc, DBC). Serum ghrelin levels were estimated
by enzyme immunoassay kit designed to detect a speci-
Table 1 Subjects characteristics
Characteristics Adolescents with CDGP
(n = 23)
Normal
control
(n = 20)
P-value
Age (years) 15.1 + 0.67 15.1 + 0.72 0.9
Weight (kg) 38.5 + 3.1 64.3 + 13.36 < 0.001*
Standing height
(cm)
147.8 + 5.9 169.55 + 9.9 < 0.001*
BMI (kg/m
2) 17.6 + 0.9 23.4 + 2.2 < 0.001*
Testicular
volume (ml)
2.6 + 0.5 11.6 + 2 < 0.001*
Bone age (years) 12.7 + 0.5 15.1 + 0.67 < 0.001*
Bone age delay
(years)
2.3 + 0.4 -
FSH (iu/ml) 0.4 + 0.08 5.1 + 0. 7 < 0.001*
LH (iu/ml) 0.2 + 0.06 4.3 + 0.7 < 0.001*
Testosterone
(ng/ml)
0.06 + 0.02 4.5 + 3.2 < 0.001*
Leptin (ng/ml) 3.06 + 0.6 7.03 + 2.5 < 0.001*
Ghrelin (ng/ml) 276.4 + 58.9 106.5 + 29.6 < 0.001*
CDGP: Constitutional delay of growth and puberty; BMI: Body mass index;
FSH: Follicle stimulating hormone; LH: Luteinizing hormone; Data are
expressed as mean ± standard deviation; *P is significant if < 0.05.
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immunoassay (DRG International inc., USA). FSH, LH
and testosterone were determined using ECLIA electro-
chemiluminescent immunoassay through automated
auto analyzer Elec Sys 2010 (Roche, Germany).
All subjects signed an informed consent to be
included in our study. The study was approved by the
local ethical committee.
Statistical analysis
Data were analyzed using SPSS statistical package ver-
sion 10 (SPSS, Inc., Chicago, IL, USA). The quantita-
tive data were presented as a mean and a standard
deviation. For the qualitative data, student t-test was
used to compare between two groups. Simple regres-
sion analysis was performed with leptin and ghrelin as
the dependent variables and all other parameters as
independent variables. Multiple regression analysis was
also performed with leptin and ghrelin as the depen-
dent variables and BMI, testicular volume, bone age,
bone age delay, FSH, LH and testosterone as indepen-
dent variables.
P value of < 0.05 indicates significant results.
Results
Clinical and biochemical characteristics of the study
subjects
Baseline characteristics of the adolescents with CDGP
and age and sex matched controls are given in Table 1.
Adolescent boys with CDGP had significantly lower
body weight, height, BMI, testicular volume and bone
age than controls. Bone age delay of the adolescent boys
with CDGP was 2.3 + 0.4 years.
FSH, LH, testosterone and leptin levels were signifi-
cantly lower (p < 0.001) in adolescent boys with CDGP
than controls. Ghrelin levels were significantly higher in
the adolescent boys with CDGP than controls (p <
0.001).
Correlations between leptin levels and all other
parameters
Leptin levels were positively correlated with height,
weight, testicular volume, bone age, FSH (p = 0.04), LH
(p = 0.038) and testosterone (p = 0.039), and negatively
correlated with bone age delay (p = 0.012) and ghrelin
(p = 0.005) Table 2.
Correlations between ghrelin levels and all other
parameters
Ghrelin levels were negatively correlated with height,
weight, BMI, testicular volume, bone age, FSH (p =
0.03), LH (p = 0.01) and testosterone (p = 0.032), and
positively correlated with bone age delay (p = 0.008)
Table 3.
Multiple regression analysis with leptin and ghrelin as the
dependent variables and other parameters as the
independent variables
A multiple regression analysis to assess the independent
effect of studied variables (BMI, testicular volume, bone
age, bone age delay, FSH, LH, testosterone) on both lep-
tin and ghrelin levels was also performed. BMI (b =
0.77, p = 0.002), FSH ((b = 0.64, p = 0.03), LH ((b =
0.66, p = 0.02), testosterone (b = 0.41, p = 0.009) and
ghrelin (b = - 0.55, p = 0.01) remained independently
correlated with leptin levels while BMI (b = -1.13, p =
0.005), LH (b = - 0.62, p = 0.01) and testosterone (b =-
0.82, p = 0.007), remained independently correlated with
ghrelin levels.
Discussion
Puberty constitutes a distinct developmental stage char-
acterized by physiological, anatomical and psychological
alterations and comprises a preparatory step for
Table 2 Correlation between leptin and cinical and
biochemical parameters in adolescents with CDGP
Parameters R P- value
Age (years) 0.13 0.5
Weight (kg) 0.62 < 0.001*
Height (cm) 0.79 0.002*
BMI (kg/m
2) 0.87 < 0.001*
Testicular volume(ml) 0.37 0.049*
Bone age(years) 0.52 0.011*
Bone age delay(years) -0.47 0.012*
FSH (iu/ml) 0.44 0.04*
LH (iu/ml) 0.42 0.038*
Testosterone (ng/ml) 0.43 0.039*
Ghrelin (ng/ml) - 0.56 0.005*
CDGP: Constitutional delay of growth and puberty; BMI: Body mass index;
FSH: Follicle stimulating hormone; LH: Luteinizing hormone; *P is significant if
< 0.05.
Table 3 Correlation between ghrelin and cinical and
biochemical parameters in adolescents with CDGP
Parameters R P- value
Age (years) - 0.15 0.4
Weight (kg) - 0.39 0.03*
Height (cm) - 0.48 0.02*
BMI (kg/m
2) - 0.46 0.02*
Testicular volume(ml) - 0.43 0.04*
Bone age(years) - 0.35 0.043*
Bone age delay(years) 0.53 0.008*
FSH (iu/ml) - 0.45 0.03*
LH (iu/ml) - 0.49 0.01*
Testosterone (ng/ml) - 0.39 0.032*
CDGP: Constitutional delay of growth and puberty; BMI: Body mass index;
FSH: Follicle stimulating hormone; LH: Luteinizing hormone; *P is significant if
< 0.05.
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and environmental factors. CDGP is a variation of the
onset and timing of pubertal development without a
defined endocrine abnormality. Recently published
results showed that both leptin and ghrelin have a role
in GnRH production at different reproductive stages
[18,20,21]; they showed opposing effects on pulsatile
GnRH secretion [18]. We hypothesized that low leptin
and high ghrelin concentrations could be implicated in
altering the tempo of puberty in adolescents with
CDGP.
In the present study, leptin levels were significantly
lower in adolescent boys with CDGP than in normal
controls. Our results also showed significant positive
correlations between leptin levels and weight, BMI, FSH,
LH and testosterone. These results are consistent with
previous reports of low leptin concentrations in boys
with CDGP [22,23]. Bideci et al. [22] also demonstrated
a statistically significant relationship between leptin
levels and hight, weight, BMI and bone age, they sug-
gested that the reason of short stature and pubertal
delay may be the decrease in weight which also the
cause of low leptin level.
Leptin is clearly significant in pubertal development
and progression [12,24]. Mantzoros et al. [25] showed
that leptin levels increase bya p p r o x i m a t e l y5 0 %b e f o r e
the onset of puberty in healthy boys before testosterone,
LH, or FSH increases and decrease to baseline values
after the initiation of puberty, which may indicate a role
for leptin in pubertal initiation. However, Ozata et al.
[26] found that leptin seems not to be a primary signal
for the onset of puberty: instead it may act in a permis-
sive way as one of several metabolic factors. In parallel
with the ob/ob mouse, humans who have rare mutations
of the leptin gene and are very obese remain prepubertal
[12] unless they are given recombinant leptin which
restores pulsatile gonadotropin secretion [27]. Further-
more, obese children have early puberty that could be
the effect of high circulating levels of leptin [28].
Leptin regulates the hypothalamus-pituitary-gonad
axis at both the central and gonadal levels [29]. Leptin
stimulates LH and FSH in pituitary gonadotrophes [30]
and also implicated in steroidogenesis in the gonads
[31]. Stimulation of reproductive neuroendocrine output
is also associated with increased circulating levels of lep-
tin [32]. Adipocytes specifically bind androgens [33] and
appear to carry androgen receptors [34]. Morelli et al.
[35] suggested that androgens (adequate hormonal sta-
tus) could have a positive effect on GnRH neuronal
activity by synergizing with leptin (adequate energy sta-
tus) in the regulatory mechanisms required for repro-
ductive and sexual fitness.
As expected we found significant elevation of ghrelin
concentrations in adolescent boys with CDGP compared
to healthy controls. Our results also showed significant
negative correlations between ghrelin and BMI, LH and
testosterone. Our results were in parallel with many stu-
dies which demonstrated negative and significant corre-
lations between ghrelin and LH and testosterone
[15,36,37]. Also, Pomerants et al. [38] found decreased
fasting ghrelin concentration and negative correlations
between its level and body weight, BMI, lean body mass
and testosterone concentrations in healthy pubertal
boys.
Ghrelin inhibits GnRH [18] and LH secretions [36] in
the pre-pubertal period. Moreover, the ghrelin and its
receptors have been demonstrated in mature Leydig and
Sertoli cells of rat and human testis [39]. Tena-Sempere
[15,37] showed that ghrelin could reduce circulating
steroid hormones in pre-pubertal male rats.
It is thought that a degree of body fat is required for
initiation of puberty and maintenance of reproductive
function in mammals. In humans, the influence of nutri-
tion and body composition on puberty and reproductive
physiology has long been recognized [40]. CDGP sub-
jects are typically underweight for height, either due to
decreased energy intake [41] or increased energy expen-
diture [42]. In our study the BMI of the adolescent boys
with CDGP were lower than that of the control group,
i tc o u l db ec o n c l u d e dt h a ta d i p o s et i s s u ei su n a b l et o
maintain adequate leptin production when a higher lep-
tin secretion is required.
Moreover, previous reports show that ghrelin level is
negatively correlated with body mass index [43] and
weight loss increases circulating ghrelin levels [44].
This increase in ghrelin level may occur as an adaptive
response to correct the abnormal energy status. Ghrelin
may function as a signal communicating the nutrition
states of the body to the central nervous system, Abou
Heif et al. [45] reported that ghrelin could be one of the
hormones responsible for the suppression of male
reproductive axis in case of negative energy balance. So
the inappropriately low leptin and high ghrelin secre-
tions could contribute to the relevant state.
Multiple regression analysis revealed that leptin was
negatively correlated with ghrelin. Leptin dose-depen-
dently inhibits ghrelin transcription in vitro [46] and
decreases ghrelin release from isolated rat stomach [47].
Komori et al. [48] provided a novel molecular link between
leptin and ghrelin signaling through the leptin-induced
negative regulatory element-binding protein which is an
important regulator of GHS-R expression in the hypotha-
lamus. So leptin and ghrelin, two hormones of opposing
metabolic effects, could be considered as permissive sig-
nals possibly synergistically in the regulatory mechanisms
required for reproductive and sexual fitness.
Ghrelin is the first identified hormone that increases
feeding when administered peripherally. Ghrelin
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increases food intake, and produces weight gain [49,50].
It remains to be determined whether the administration
of ghrelin, ghrelin analogues, or small molecule agonists
will be useful to treat conditions such as CDGP.
Conclusions
From the previous discussion it seems that the adipose-
derived hormone leptin and gastrointestinal-derived hor-
mone ghrelin communicate information about metabolic
status and body weight to the hypothalamus to initiate
puberty, so ghrelin and leptin represent metabolic gate
for puberty. Elevated serum ghrelin and decreased leptin
concentrations and their associations with reproductive
hormones may explain the sexual immaturity in adoles-
cents with CDGP.
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